SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-068094
Filing Date
2015-11-25
Accepted
2015-11-25 16:23:32
Documents
5
Period of Report
2015-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v425617_8k.htm 8-K 31775
2 EXHIBIT 3.1 v425617_ex3-1.htm EX-3.1 41957
3 EXHIBIT 4.1 v425617_ex4-1.htm EX-4.1 308873
4 EXHIBIT 99.1 v425617_ex99-1.htm EX-99.1 20326
5 GRAPHIC image_001.jpg GRAPHIC 21239
  Complete submission text file 0001144204-15-068094.txt   433708
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 151256451
SIC: 2834 Pharmaceutical Preparations